Pathway-based association analyses identified TRAIL pathway for osteoporotic fractures
Yin-Ping Zhang1, Yao-Zhong Liu, Yan Guo
1The Key Laboratory of Environment and Genes Related to Diseases, Xi'an Jiaotong University College of Medicine, Ministry of Education, Xi'an, Shaanxi, People's Republic of China. cathyzh@mail.xjtu.edu.cn
Plos One
|July 16, 2011
Summary
The Tumor Necrosis Factor (TNF)-Related Apoptosis-Inducing Ligand (TRAIL) pathway is associated with hip Osteoporosis (OF) in the Chinese Han population. Specific genes within this pathway may influence osteoporosis risk and protection.
Area of Science:
- Genetics
- Bone Metabolism
- Molecular Biology
Background:
- Hip Osteoporosis (OF) is a significant cause of morbidity and mortality.
- Previous research suggests a link between the Tumor Necrosis Factor (TNF)-Related Apoptosis-Inducing Ligand (TRAIL) pathway and bone metabolism.
- The specific role of the TRAIL pathway in hip OF pathogenesis requires further investigation.
Purpose of the Study:
- To investigate the potential association between the TRAIL pathway and hip OF.
- To identify specific genes within the TRAIL pathway that may contribute to hip OF risk.
Main Methods:
- Genome-wide genotype data from Affymetrix 500K SNP arrays were analyzed.
- Pathway-based association analyses were conducted.
- The study included 700 elderly Chinese Han subjects (350 with hip OF and 350 controls).
Main Results:
- The TRAIL pathway showed a significant association with hip OF (p=0.01).
- Seven genes within the pathway were nominally associated with hip OF, with TNFSF10 (TRAIL) being the most significant (p=1.70×10(-4)).
- Specific SNPs in genes like TNFSF10 and TNFRSF10B were associated with increased hip OF risk, while others in CFLAR, NFKB1, TNFSF11, TNFRSF11A, and TRAF3 showed protective effects.
Conclusions:
- The TRAIL pathway plays a potential role in the pathogenesis of hip OF within the Chinese Han population.
- Further functional studies are warranted to elucidate the precise mechanisms by which the TRAIL pathway influences hip OF risk.
Related Concept Videos
Fractures: Bone Repair
Treatment for a fracture is based on the type of break, the bone affected, and the patient's age.
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the procedure...
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the procedure...
Osteoclasts in Bone Remodeling
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Bone Remodeling and Repair
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Bone Disorders
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...

